發(fā)布時(shí)間：2019-02-15 11:28

【摘要】：目的觀察圍絕經(jīng)期2型糖尿病骨質(zhì)疏松癥治療中胰島素與阿侖膦酸鈉的聯(lián)合應(yīng)用效果。方法 168例圍絕經(jīng)期2型糖尿病骨質(zhì)疏松癥患者,隨機(jī)分為胰島素+阿侖膦酸鈉組、胰島素組、阿侖膦酸鈉組、對(duì)照組,每組42例。各組均口服骨化三醇膠丸0.25μg+碳酸鈣D3 600 mg+二甲雙胍1 500 mg/d口服,1次/d。胰島素+阿侖膦酸鈉組,胰島素0.5 IU/(kg.d)皮下注射,2次/d,口服阿侖膦酸鈉70 mg,1次/周;胰島素組使用胰島素早晚餐前皮下注射,劑量為0.5 IU/(kg.d);阿侖膦酸鈉組口服阿侖膦酸鈉70 mg,1次/周。共治療12個(gè)月。治療前、后采用測定各組腰椎和全髖骨密度(BMD)。治療前、后抽取各組空腹靜脈血5 mL,采用自動(dòng)生化分析儀檢測空腹血糖,采用美國RAD公司試劑盒檢測糖化血紅蛋白(HbA_(1c)),采用ELISA法檢測血清骨保護(hù)素(OPG),采用酶聯(lián)免疫法檢測Ⅰ型膠原C端肽(CTX)。結(jié)果與治療前比較,治療后胰島素+阿侖膦酸鈉組腰椎、全髖BMD增加(P均0.05);與胰島素組、阿侖膦酸鈉組、對(duì)照組治療后比較,胰島素+阿侖膦酸鈉組腰椎、全髖BMD增加(P均0.05)。與治療前比較,治療后各組空腹血糖、HbA_(1c)均降低(P均0.05)。與治療前比較,治療后胰島素+阿侖膦酸鈉組血清OPG水平升高、CTX水平降低(P均0.05);與胰島素組、阿侖膦酸鈉組、對(duì)照組治療后比較,胰島素+阿侖膦酸鈉組OPG水平升高、CTX水平降低(P均0.05)。結(jié)論圍絕經(jīng)期2型糖尿病骨質(zhì)疏松癥治療中胰島素與阿侖膦酸鈉的聯(lián)合應(yīng)用效果較好。
[Abstract]:Objective to observe the effect of insulin combined with alendronate in the treatment of type 2 diabetic osteoporosis. Methods 168 cases of peri-menopausal type 2 diabetic osteoporosis were randomly divided into insulin alendronate group, insulin group, alendronate group and control group (42 cases in each group). Each group was treated with 0.25 渭 g calcium carbonate D3 600 mg metformin 1 500 mg/d orally, once a day. In insulin alendronate group, insulin 0.5 IU/ (kg.d) was injected subcutaneously twice a day, and alendronate was given orally for 70 mg,1 / week. The insulin group was subcutaneously injected with insulin in the morning and evening preprandial period (kg.d), and alendronate sodium was administered orally in the alendronate group for 70 mg,1 / week. The treatment lasted 12 months. Before and after treatment, the bone density of lumbar vertebrae and total hip were measured by (BMD). In each group. Before and after treatment, fasting venous blood was extracted for 5 mL, and fasting blood glucose was detected by automatic biochemical analyzer. HbA_ (1c), ELISA method) was used to detect serum osteoprotegerin (OPG), and HbA_ (1c),) was used to detect glycosylated hemoglobin (HbA_). Detection of type I collagen C-terminal peptide (CTX). By enzyme-linked immunosorbent assay Results compared with before treatment, the total hip BMD increased in the insulin alendronate group after treatment (P 0.05). Compared with insulin group, alendronate group and control group, BMD of lumbar vertebrae and total hip in insulin alendronate group increased after treatment (all P 0. 05). Compared with before treatment, fasting blood glucose and HbA_ (1c) in each group were decreased after treatment (P < 0. 05). Compared with before treatment, serum OPG level increased and CTX level decreased in insulin alendronate group after treatment (all P 0. 05). Compared with insulin group, alendronate group and control group, OPG level increased and CTX level decreased in insulin alendronate group. Conclusion the combination of insulin and alendronate is effective in the treatment of type 2 diabetic osteoporosis.
【作者單位】： 深圳市第二人民醫(yī)院;
【基金】：深圳市科技研發(fā)資金項(xiàng)目資助項(xiàng)目(JCYJ20150330102720148) 深圳市衛(wèi)生計(jì)生系統(tǒng)科研項(xiàng)目(201506021)
【分類號(hào)】：R580;R587.1

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;阿侖膦酸鈉與房顫[J];河南醫(yī)學(xué)研究;2008年02期

2 張玉蘭,趙麗茹,楊肖薈;阿侖膦酸鈉治療絕經(jīng)后骨質(zhì)疏松性骨痛的研究[J];中國骨質(zhì)疏松雜志;2000年02期

3 于濤,邵延坤,邵璞,劉玉槐;阿侖膦酸鈉治療原發(fā)性骨質(zhì)疏松癥[J];現(xiàn)代康復(fù);2001年02期

4 李梅,孟迅吾,邢小平,周學(xué)瀛,夏維波,胡瑩瑩,劉懷成;阿侖膦酸鈉治療37例絕經(jīng)后骨質(zhì)疏松癥的療效及觀察[J];基礎(chǔ)醫(yī)學(xué)與臨床;2003年03期

5 孟迅吾;朱漢民;劉建立;羅邦堯;謝海寶;張光健;李佛保;李梅;;阿侖膦酸鈉治療絕經(jīng)后骨質(zhì)疏松癥的療效與耐受性[J];基礎(chǔ)醫(yī)學(xué)與臨床;2007年02期

6 李慧玲;;阿侖膦酸鈉治療老年性骨質(zhì)疏松癥療效觀察[J];中國社區(qū)醫(yī)師(綜合版);2007年24期

7 榮青峰;;阿侖膦酸鈉聯(lián)合樂力治療老年男性骨質(zhì)疏松癥療效觀察[J];臨床醫(yī)藥實(shí)踐雜志;2008年12期

8 王東巖;沙正達(dá);;針刺結(jié)合口服阿侖膦酸鈉對(duì)絕經(jīng)后骨質(zhì)疏松癥前臂骨密度的影響[J];江蘇中醫(yī)藥;2008年12期

9 聶新華;;阿侖膦酸鈉治療絕經(jīng)后骨質(zhì)疏松癥50例臨床觀察[J];現(xiàn)代醫(yī)院;2008年02期

10 陳援越;史曉林;劉建芳;廖筱美;;雌孕激素聯(lián)合阿侖膦酸鈉治療圍絕經(jīng)期骨量減少[J];中國骨質(zhì)疏松雜志;2008年07期

相關(guān)會(huì)議論文 前10條

1 劉玉槐;劉佐慶;王宏;;阿侖膦酸鈉治療原發(fā)性骨質(zhì)疏松癥[A];全國老年骨質(zhì)疏松專題學(xué)術(shù)研討會(huì)論文匯編[C];2000年

2 裴育;王熙然;李劍;呂朝暉;陸菊明;竇京濤;;阿侖膦酸鈉在1例青春期成骨不全患者中的應(yīng)用[A];中華醫(yī)學(xué)會(huì)第十二次全國內(nèi)分泌學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2013年

3 張學(xué)軍;李蓮秋;;口服阿侖膦酸鈉致食道糜爛1例[A];中華醫(yī)學(xué)會(huì)第三次全國骨質(zhì)疏松和骨礦鹽疾病學(xué)術(shù)會(huì)議暨骨質(zhì)疏松診斷技術(shù)繼續(xù)教育學(xué)習(xí)班論文匯編[C];2004年

4 周沛然;洪霞;夏維波;邢小平;韓蘭穩(wěn);姜艷;王鷗;徐苓;李梅;;阿侖膦酸鈉對(duì)絕經(jīng)后骨質(zhì)疏松癥患者生活質(zhì)量的影響[A];中華醫(yī)學(xué)會(huì)第十二次全國內(nèi)分泌學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2013年

5 周沛然;洪霞;夏維波;邢小平;韓蘭穩(wěn);姜艷;王鷗;徐芩;李梅;;阿侖膦酸鈉對(duì)絕經(jīng)后骨質(zhì)疏松癥患者生活質(zhì)量的影響[A];中華醫(yī)學(xué)會(huì)第五次中青年骨質(zhì)疏松和骨礦鹽疾病學(xué)術(shù)會(huì)議論文集[C];2013年

6 李征宇;劉建;;阿侖膦酸鈉不同給藥方案治療絕經(jīng)后婦女骨質(zhì)疏松癥效果研究[A];中華醫(yī)學(xué)會(huì)第七次全國骨質(zhì)疏松和骨礦鹽疾病學(xué)術(shù)會(huì)議論文匯編[C];2013年

7 閻德文;羅國春;;阿侖膦酸鈉對(duì)糖皮質(zhì)激素治療亞甲炎的骨保護(hù)作用[A];第九屆全國骨質(zhì)疏松年會(huì)暨第六屆全國鈣劑年會(huì)會(huì)議文集[C];2003年

8 汪冉;楊永宏;王p，

本文編號(hào)：2423297